Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cystathionine beta-Synthase Deficiency Disease
|
118 | 0.701 | 0.360 | 21 | 43063074 | missense variant | A/G | snv | 0.850 | 0.974 | 39 | 1984 | 2019 | ||||||
Homocystinuria
|
27 | 0.701 | 0.360 | 21 | 43063074 | missense variant | A/G | snv | 0.760 | 0.933 | 15 | 1995 | 2019 | ||||||
Homocystinuria, Pyridoxine-Responsive
|
11 | 0.701 | 0.360 | 21 | 43063074 | missense variant | A/G | snv | 0.720 | 1.000 | 2 | 1995 | 2007 | ||||||
HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED
|
24 | 0.701 | 0.360 | 21 | 43063074 | missense variant | A/G | snv | 0.700 | 1.000 | 18 | 1991 | 2014 | ||||||
Hyperhomocysteinemia
|
45 | 0.701 | 0.360 | 21 | 43063074 | missense variant | A/G | snv | 0.030 | 1.000 | 3 | 1999 | 2012 | ||||||
Endothelial dysfunction
|
25 | 0.701 | 0.360 | 21 | 43063074 | missense variant | A/G | snv | 0.020 | 1.000 | 2 | 2012 | 2019 | ||||||
Anxiety
|
287 | 0.701 | 0.360 | 21 | 43063074 | missense variant | A/G | snv | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||
Anxiety Disorders
|
163 | 0.701 | 0.360 | 21 | 43063074 | missense variant | A/G | snv | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||
Atherothrombosis
|
15 | 0.701 | 0.360 | 21 | 43063074 | missense variant | A/G | snv | 0.010 | 1.000 | 1 | 2002 | 2002 | ||||||
Attention deficit hyperactivity disorder
|
420 | 0.701 | 0.360 | 21 | 43063074 | missense variant | A/G | snv | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||||
Bipolar Disorder
|
839 | 0.701 | 0.360 | 21 | 43063074 | missense variant | A/G | snv | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||||
Bone Demineralization, Pathologic
|
3 | 0.701 | 0.360 | 21 | 43063074 | missense variant | A/G | snv | 0.010 | 1.000 | 1 | 1995 | 1995 | ||||||
Cardiovascular Diseases
|
711 | 0.701 | 0.360 | 21 | 43063074 | missense variant | A/G | snv | 0.010 | 1 | 1996 | 1996 | |||||||
Cerebrovascular accident
|
591 | 0.701 | 0.360 | 21 | 43063074 | missense variant | A/G | snv | 0.010 | 1.000 | 1 | 2012 | 2012 | ||||||
Complete Trisomy 21 Syndrome
|
77 | 0.701 | 0.360 | 21 | 43063074 | missense variant | A/G | snv | 0.010 | 1.000 | 1 | 2013 | 2013 | ||||||
Down Syndrome
|
80 | 0.701 | 0.360 | 21 | 43063074 | missense variant | A/G | snv | 0.010 | 1.000 | 1 | 2013 | 2013 | ||||||
Hyperactive behavior
|
112 | 0.701 | 0.360 | 21 | 43063074 | missense variant | A/G | snv | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||||
Osteopenia
|
61 | 0.701 | 0.360 | 21 | 43063074 | missense variant | A/G | snv | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||||
Peripheral Arterial Diseases
|
128 | 0.701 | 0.360 | 21 | 43063074 | missense variant | A/G | snv | 0.010 | 1.000 | 1 | 2011 | 2011 | ||||||
Thrombophilia
|
43 | 0.701 | 0.360 | 21 | 43063074 | missense variant | A/G | snv | 0.010 | 1.000 | 1 | 2000 | 2000 | ||||||
Vitiligo
|
249 | 0.701 | 0.360 | 21 | 43063074 | missense variant | A/G | snv | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||
VITILIGO-ASSOCIATED MULTIPLE AUTOIMMUNE DISEASE SUSCEPTIBILITY 1 (finding)
|
92 | 0.701 | 0.360 | 21 | 43063074 | missense variant | A/G | snv | 0.010 | 1.000 | 1 | 2019 | 2019 |